While our transcriptomic analysis points to differences in immune-related signals (e.g., TRAIL; HRBB3, Decorin, etc.)and suggests varying levels of lymphocyte infiltration between SET and classic tumors, it is necessary to validate these differences by examining the actual immune cell populations and other stromal constituents in the tumor tissue. Here, TNFSF10 is linked to neoplasm.